(Q35745848)

10 August 2017

Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. (English)

1 reference

10 August 2017

1 reference

M H Poczatek

1

1 reference

10 August 2017

C Hugo

series ordinal

2

1 reference

10 August 2017

V Darley-Usmar

series ordinal

3

1 reference

10 August 2017

J E Murphy-Ullrich

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

The American Journal of Pathology

10 August 2017

1 reference

10 August 2017

157

1 reference

10 August 2017

1353-1363

1 reference

10 August 2017

4

1 reference

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Identification of glucose-regulated genes in human mesangial cells by mRNA differential display

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Latent transforming growth factor-beta: structural features and mechanisms of activation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Transforming growth factor-beta: a general review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Redox-mediated activation of latent transforming growth factor-beta 1

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

The extracellular matrix in diabetic nephropathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Thrombospondin secretion by cultured human glomerular mesangial cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Role for carbohydrate structures in TGF-beta 1 latency

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

The renal tubulointerstitium in diabetes mellitus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Activated platelets in subjects at increased risk of IDDM. DENIS Study Group. Deutsche Nikotinamid Interventionsstudie.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Identification and characterization of novel airway epithelial integrins

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850177

Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Increased renal production of transforming growth factor-beta1 in patients with type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

ECM Gene Expression and Its Modulation by Insulin in Diabetic Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

The fibronectin production is increased by thrombospondin via activation of TGF-beta in cultured human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

High glucose reduces generation of plasmin activity by mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

Impaired nitric oxide release by glomeruli from diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964649-4

High glucose inhibits nitric oxide production in cultured rat mesangial cells

7 January 2021

1 reference

12 December 2020

TGF-beta: structure, function, and formation

1 reference

12 December 2020

The emerging role of transforming growth factor-beta in kidney diseases

1 reference

12 December 2020

Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system

1 reference

12 December 2020

Thrombospondin 1 as an enzyme inhibitor

1 reference

12 December 2020

10.1016/S0002-9440(10)64649-4

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference